TY - JOUR
T1 - Evaluation of microbial‐fructo‐oligosaccharides metabolism by human gut microbiota fermentation as compared to commercial inulin‐derived oligosaccharides
AU - Roupar, Dalila
AU - Coelho, Marta C.
AU - Gonçalves, Daniela A.
AU - Silva, Soraia P.
AU - Coelho, Elisabete
AU - Silva, Sara
AU - Coimbra, Manuel A.
AU - Pintado, Manuela
AU - Teixeira, José A.
AU - Nobre, Clarisse
N1 - Funding Information:
Funding: Dalila Roupar: Soraia Silva and Marta Coelho acknowledge the Portuguese Foundation for Science and Technology (FCT) for their PhD Grants (SFRH/BD/139884/2018, SFRH/BD/136471/2018, and SFRH/BD/111884/2015, respectively). Elisabete Coelho thanks the re‐ search contract (CDL‐CTTRI‐88‐ARH/2018‐REF. 049‐88‐ARH/2018) funded by national funds (OE), through FCT, in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of article 23, of the Decree‐Law 57/2016, of August 29, changed by Law 57/2017, of July 19. This study was supported by the FCT under the scope of the strategic funding of UIDB/04469/2020 and UIDB/50016/2020 unit, and LAQV/REQUIMTE (UIDB/50006/2020, UIDP/50006/2020) through na‐ tional founds and, where applicable, co‐financed by the FEDER, within the PT2020 Partnership Agreement, and the Project ColOsH PTDC/BTM‐SAL/30071/2017, also by the European Regional Development Fund (ERDF) through the Competitiveness factors Operational program, Norte 2020, COMPETE, and by National Funds through the FCT under the project AgriFood XXI (NORTE‐01‐ 0145‐FEDER‐000041), and the project cLabel+ (POCI‐01‐0247‐FEDER‐046080) co‐financed by Com‐ pete 2020, Lisbon 2020, Portugal 2020 and the European Union, through the European Regional Development Fund (ERDF).
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - The prebiotic potential of fructo‐oligosaccharides (microbial‐FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non‐microbial commercial FOS sample. Prebiotics were fermented in vitro by fecal microbiota of five healthy volunteers. Microbial‐FOS significantly stimulated the growth of Bifidobacterium probiotic strains, triggering a beneficial effect on gut microbiota composition. A higher amount of total short‐chain fatty acids (SCFA) was produced by microbial‐FOS fermentation as compared to commercial‐FOS, particularly propionate and butyrate. Inulin neoseries oligosaccharides, with a degree of polymerization (DP) up to 5 (e.g., ne-okestose and neonystose), were identified only in the microbial‐FOS mixture. More than 10% of the microbial‐oligosaccharides showed a DP higher than 5. Differences identified in the structures of the FOS samples may explain their different functionalities. Results indicate that microbial‐FOS exhibit promising potential as nutraceutical ingredients for positive gut microbiota modulation.
AB - The prebiotic potential of fructo‐oligosaccharides (microbial‐FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non‐microbial commercial FOS sample. Prebiotics were fermented in vitro by fecal microbiota of five healthy volunteers. Microbial‐FOS significantly stimulated the growth of Bifidobacterium probiotic strains, triggering a beneficial effect on gut microbiota composition. A higher amount of total short‐chain fatty acids (SCFA) was produced by microbial‐FOS fermentation as compared to commercial‐FOS, particularly propionate and butyrate. Inulin neoseries oligosaccharides, with a degree of polymerization (DP) up to 5 (e.g., ne-okestose and neonystose), were identified only in the microbial‐FOS mixture. More than 10% of the microbial‐oligosaccharides showed a DP higher than 5. Differences identified in the structures of the FOS samples may explain their different functionalities. Results indicate that microbial‐FOS exhibit promising potential as nutraceutical ingredients for positive gut microbiota modulation.
KW - Aspergillus ibericus
KW - Glycosidic linkage analysis
KW - NeoFOS
KW - Prebiotics
KW - qPCR
KW - Short‐chain fatty acids
UR - http://www.scopus.com/inward/record.url?scp=85128180868&partnerID=8YFLogxK
U2 - 10.3390/foods11070954
DO - 10.3390/foods11070954
M3 - Article
C2 - 35407041
AN - SCOPUS:85128180868
SN - 2304-8158
VL - 11
JO - Foods
JF - Foods
IS - 7
M1 - 954
ER -